Market Exclusive

Analyst Activity – Cann Reiterates Buy on NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS)

Analyst Ratings For NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS)

Today, Cann reiterated its Buy rating on NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS) with a price target of $28.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS)
NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS) has insider ownership of 27.80% and institutional ownership of 48.85%.

Recent Trading Activity for NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS)
Shares of NASDAQ:SYRS – Syros Pharmaceuticals closed the previous trading session at 11.84 down -0.34 2.79% with 12.119999885559082 shares trading hands.

Exit mobile version